Get started
Author

Rami Massie

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
2017 · James F Howard, Kimiaki Utsugisawa, et al. · The Lancet Neurology · 846
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
2023 · Vera Bril, Vera Bril, et al. · The Lancet Neurology · 294
Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia
2022 · David Pellerin, Matt C. Danzi, et al. · New England Journal of Medicine · 263
PDF
Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies
2012 · R. Massie, M. L. Mauermann, et al. · Brain · 126
PDF
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis
2020 · Nowell M. Fine, Margot K. Davis, et al. · Canadian Journal of Cardiology · 113
Polymerase Gamma 1 Mutations
2010 · Margherita Milone, Rami Massie · The Neurologist · 97
Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy
2012 · J.J. Figueroa, P.J.B. Dyck, et al. · Neurology · 84
PDF
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
2017 · Vincent Meininger, Angela Genge, et al. · The Lancet Neurology · 81
PDF
Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
2018 · Richard Hughes, Marinos C Dalakas, et al. · The Lancet Neurology · 77
Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients
2020 · Alain Meyer, Yves Troyanov, et al. · Arthritis Research & Therapy · 71
PDF
Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy
2021 · David R Cornblath, Pieter A van Doorn, et al. · Brain · 47
PDF
Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis
2026 · Timothy M. Miller, Merit E. Cudkowicz, et al. · JAMA Neurology · 40
PDF
Autoimmune peripheral neuropathies
2015 · Pierre R. Bourque, Jodi Warman Chardon, et al. · Clinica Chimica Acta · 39
Autoantibody profiles delineate distinct subsets of scleromyositis
2021 · Valérie Leclair, Julie D’Aoust, et al. · Lara D. Veeken · 33
MTP deficiency caused by HADHB mutations: Pathophysiology and clinical manifestations
2021 · Robin Dagher, Rami Massie, et al. · Molecular Genetics and Metabolism · 30
Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management
2021 · Monica Alcantara, Michelle M. Mezei, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 28
PDF
The Canadian Neuromuscular Disease Registry 2010–2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-NeuromuscularDisease Registry
2020 · V. Hodgkinson, J. Lounsberry, et al. · Journal of Neuromuscular Diseases · 27
PDF
A National Spinal Muscular Atrophy Registry for Real-World Evidence
2020 · Victoria L. Hodgkinson, Maryam Oskoui, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 25
PDF
Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis
2018 · Victoria L. Hodgkinson, Josh Lounsberry, et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 22
PDF
Exercise intolerance due to cytochrome b mutation
2010 · Rami Massie, Lee‐Jun C. Wong, et al. · Muscle & Nerve · 22
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
2023 · Laura Obici, Senda Ajroud-Driss, et al. · Neurology and Therapy · 21
PDF
Temporal evolution of nerve conduction study abnormalities in anti‐myelin‐associated glycoprotein neuropathy
2020 · Pierre R. Bourque, Josée Masson‐Roy, et al. · Muscle & Nerve · 13
A New Mutation in FIG4 Causes a Severe Form of CMT4J Involving TRPV4 in the Pathogenic Cascade
2017 · Benoit J. Gentil, Erin O’Ferrall, et al. · Journal of Neuropathology & Experimental Neurology · 12
PDF
Delineating the pathogenic threshold and phenotypic spectrum of SCA27B: findings from a large French–Canadian cohort
2025 · Pablo Iruzubieta, David Pellerin, et al. · Journal of Neurology · 11
PDF
Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study
2025 · Vera Bril, Artur Drużdż, et al. · Journal of Neurology · 11
Works count: 83
Citation count: 2,545
H-index: 21
I10-index: 26
Year
Topic
Type